China Biologic Products Holdings Inc (CBPO.OQ)
CBPO.OQ on NASDAQ Stock Exchange Global Select Market
85.73USD
20 Apr 2018
85.73USD
20 Apr 2018
Change (% chg)
$-1.39 (-1.60%)
$-1.39 (-1.60%)
Prev Close
$87.12
$87.12
Open
$86.88
$86.88
Day's High
$86.88
$86.88
Day's Low
$85.14
$85.14
Volume
58,062
58,062
Avg. Vol
73,391
73,391
52-wk High
$120.01
$120.01
52-wk Low
$71.87
$71.87
About
China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product... (more)
Overall
| Beta: | 1.49 |
| Market Cap(Mil.): | $2,840.26 |
| Shares Outstanding(Mil.): | 33.13 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBPO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 188.22 | 33.60 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | -0.74 | 13.19 |
| ROE: | -- | -2.80 | 15.00 |
BRIEF-China Biologic Reports Q4 Adjusted Non-GAAP Earnings Per Share $0.90
* CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2017
BRIEF-China Biologic To Build New Collection Station In Hainan Province
* CHINA BIOLOGIC TO BUILD NEW COLLECTION STATION IN HAINAN PROVINCE
BRIEF-Marc Chan Reports 9.5 Percent Passive Stake In China Biologic Products Holdings As Of Dec 31, 2017
* MARC CHAN REPORTS 9.5 PERCENT PASSIVE STAKE IN CHINA BIOLOGIC PRODUCTS HOLDINGS INC AS OF DEC 31, 2017 - SEC FILING Source text - (http://bit.ly/2CffxTI) Further company coverage:
BRIEF-China Biologic Receives Operating Permit For New Collection Facility In Ju County In Shandong Province
* CHINA BIOLOGIC RECEIVES OPERATING PERMIT FOR NEW COLLECTION FACILITY IN JU COUNTY IN SHANDONG PROVINCE Source text for Eikon: Further company coverage:
BRIEF-China Biologic posts Q3 adj. earnings per share $1.38
* China Biologic reports unaudited financial results for the third quarter of 2017
Estimates